Feeling "Frisky" Makes You See What You Want To SeeNews
A group of psychologists discovered that we see possible romantic partners as a lot more attractive if we have what the scientists call "a sexy mindset." Under the same condition we also tend to overestimate our own chances of romantic success.
Mouse Study Shows Links Between Sleep Disturbances and Gut MicrobiotaNews
Obstructive sleep apnea (OSA) is a chronic sleep condition affecting more than one billion people worldwide. Researchers have discovered how OSA-related sleep disturbances affect the gut microbiome in mice and how transplanting those gut bacteria into other mice can cause changes to sleep patterns in the recipient mice.
Team Uncovers New Mechanism of Action Against SARS-CoV-2 by RemdesivirNews
Researchers have discovered a novel, second mechanism of action by the antiviral drug remdesivir against SARS-CoV-2, according to findings published in the Journal of Biological Chemistry.READ MORE
Patients Taking Certain HIV Drugs Had a 33% Lower Risk of Developing DiabetesNews
A group of drugs used to treat HIV and hepatitis B could be repurposed to prevent Type 2 diabetes, according to a newly published study.READ MORE
The research builds on a body of evidence suggesting the importance of Caucasians that carries the gene variation.READ MORE
Joseph Cross, Nanophase’s president and CEO, will address the conference.READ MORE
Open Biosystems' Open Access RNAi Program provides CIC bioGUNE with shRNAmir technology.READ MORE
The key finding of the study was that variants of the VAMP8 and HNRPUL1 genes were associated with early-onset MI.READ MORE
The agreement is centred on synergies between the Agilent 2100 bioanalyzer 'lab-on-a-chip' platform and Nonlinear’s TL120 DM software.READ MORE
Study shows peripheral blood-based gene expression assay can be employed to discriminate patients with Parkinson and Alzheimer’s disease.READ MORE
SAFE created and manages the SAFE™ digital identity and signature standard used in the pharmaceutical industry.READ MORE
Laureate to cGMP manufacture hI-con1 protein to be used by Iconic in clinical trials for treatment of macular degeneration and cancer.READ MORE